Work

Phase I study combining the aurora kinase A (AURKA) inhibitor alisertib (Ali) with mFOLFOX in gastrointestinal (GI) cancer.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.2593

Authors: Laura Williams Goff, Nilofer Saba Azad, Stacey Stein, Jennifer Whisenant, Ulka N. Vaishampayan, Howard S. Hochster, Roisin M. Connolly, Amy M. Weise, Patricia LoRusso, Wael El-Rifai, Jordan Berlin

Institutions: Vanderbilt University Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Yale University, Vanderbilt University, The Barbara Ann Karmanos Cancer Institute, Yale Cancer Center, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2776634906

Cites:

Cited by:

Related to: 10